CANF - Can-Fite BioPharma Ltd.

NYSE American - NYSE American Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 58.74M
Enterprise Value 3610.67k
Trailing P/E N/A
Forward P/E 1-0.65
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)2.51
Price/Book (mrq)1.23
Enterprise Value/Revenue 30.17
Enterprise Value/EBITDA 6-0.11

Trading Information

Stock Price History

Beta (3Y Monthly) 1.88
52-Week Change 3-85.63%
S&P500 52-Week Change 3-0.33%
52 Week High 325.9500
52 Week Low 32.3700
50-Day Moving Average 32.8574
200-Day Moving Average 38.4295

Share Statistics

Avg Vol (3 month) 3272.16k
Avg Vol (10 day) 335.2k
Shares Outstanding 53.32M
Float 1.11M
% Held by Insiders 10.00%
% Held by Institutions 121.13%
Shares Short (Jul 31, 2019) 4324.69k
Short Ratio (Jul 31, 2019) 44.08
Short % of Float (Jul 31, 2019) 4N/A
Short % of Shares Outstanding (Jul 31, 2019) 49.77%
Shares Short (prior month Jun 28, 2019) 4207.14k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 215/1
Last Split Date 3May 10, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin -191.63%
Operating Margin (ttm)-158.79%

Management Effectiveness

Return on Assets (ttm)-34.67%
Return on Equity (ttm)-125.20%

Income Statement

Revenue (ttm)3.49M
Revenue Per Share (ttm)2.52
Quarterly Revenue Growth (yoy)-52.70%
Gross Profit (ttm)3.82M
EBITDA -5.52M
Net Income Avi to Common (ttm)-6.68M
Diluted EPS (ttm)-4.8000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.21M
Total Cash Per Share (mrq)2.1
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.75
Book Value Per Share (mrq)2.13

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A